| 1 |
Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2015: Available from:
URL
|
| 2 |
Battaglia S, Benfante A, Spatafora M, et al. Asthma in the elderly: a different disease？[J]. Breathe (Sheff), 2016, 12(1): 18-28.
|
| 3 |
Milanese M, Di Marco F, Corsico AG, et al. Asthma control in elderly asthmatics. An Italian observational study[J]. Respir Med, 2014, 108(8): 1091-1099.
|
| 4 |
Yáñez A, Cho SH, Soriano JB, et al. Asthma in the elderly: what we know and what we have yet to know [J]. World Allergy Organ J, 2014, 7(1): 1-16.
|
| 5 |
蔡绍曦. 老年性哮喘[J]. 实用医学杂志，2001, 17(7): 569-570.
|
| 6 |
Bauer BA, Reed CE, Yunginger JW, et al. Incidence and outcomes of asthma in the elderly. A population-based study in rochester, minnesota[J]. Chest, 1997, 111(2): 303-310.
|
| 7 |
Evers U, Jones SC, Caputi P, et al. The asthma knowledge and perceptions of older Australian adults: implications for social marketing campaigns[J]. Patient Educ Couns, 2013, 91(3): 392-399.
|
| 8 |
Song WJ, Morice AH, Kim MH, et al. Cough in the elderly population：relationships with multiple comorbidity[J]. PLoS One, 2013, 8(10): e78081.
|
| 9 |
Bellia V, Battaglia S, Catalano F, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study[J]. Chest, 2003, 123(4): 1066-1072.
|
| 10 |
Sano H, Iwanaga T, Nishiyama O, et al. Characteristics of phenotypes of elderly patients with asthma[J]. Allergol Int, 2016, 65(2): 204-209.
|
| 11 |
Inoue H, Niimi A, Takeda T, et al. Pathophysiological characteristics of asthma in the elderly: a comprehensive study[J]. Ann Allergy Asthma Immunol, 2014, 113(5): 527-533.
|
| 12 |
Kauppi P, Linna M, Jantunen J, et al. Chronic Comorbidities Contribute to the burden and costs of persistent asthma[J]. Mediators Inflamm, 2015, 2015: 819194.
|
| 13 |
Wardzynska A, Kubsik B, Kowalski ML. Comorbidities in elderly patients with asthma: Association with control of the disease and concomitant treatment[J]. Geriatr Gerontol Int, 2015, 15(7): 902-909.
|
| 14 |
李莉，郭英. 52例老年哮喘临床分析[J]. 临床肺科杂志，2004, 9(6): 617-619.
|
| 15 |
Bozek A, Filipowski M, Fischer A, et al. Characteristics of atopic bronchial asthma in seniors over 80 years of age[J]. Biomed Res Int, 2013, 2013: 689782.
|
| 16 |
Tsai CL, Delclos GL, Huang JS, et al. Age-related differences in asthma outcomes in the United States, 1988-2006[J]. Ann Allergy Asthma Immunol, 2013, 110(4): 240-246.
|
| 17 |
Melani AS. Management of asthma in the elderly patient[J]. Clin Interv Aging, 2013, 8: 913-922.
|
| 18 |
Tsai CL, Lee WY, Hanania NA, et al. Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008[J]. J Allergy Clin Immunol, 2012, 129(5): 1252-1258.
|
| 19 |
Sumi Y, Hamid Q. Airway remodeling in asthma[J]. Allergol Int, 2007, 56(4): 341-348.
|
| 20 |
Kraneveld AD, James DE, de Vries A, et al. Excitatory non-adrenergic-non-cholinergic neuropeptides: key players in asthma[J]. Eur J Pharmacol, 2000, 405(1-3): 113-129.
|
| 21 |
Franca-Pinto A, Mendes FA, de Carvalho-Pinto RM, et al. Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial[J]. Thorax, 2015, 70(8): 732-739.
|
| 22 |
Harnett CM, Hunt EB, Bowen BR, et al. A study to assess inhaler technique and its potential impact on asthma control in patients attending an asthma clinic[J]. J Asthma, 2014, 51(4): 440-445.
|
| 23 |
Kapadia SG, Wei C, Bartlett SJ, et al. Obesity and symptoms of depression contribute independently to the poor asthma control of obesity[J]. Respir Med, 2014, 108(8): 1100-1107.
|
| 24 |
潘亦林，朱燕亭，李满祥. 支气管哮喘气道重塑的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(6): 773-776.
|
| 25 |
Kim MY, Song WJ, Cho SH. Pharmacotherapy in the management of asthma in the elderly: a review of clinical studies[J]. Asia Pac Allergy, 2016, 6(1): 3-15.
|
| 26 |
Bousquet J, Busse WW. Section 1. EPR-3 versus GINA 2008 Guidelines-Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the Guidelines[J]. World Allergy Organ J, 2010, 3(2): 16-22.
|
| 27 |
Cates CJ, Wieland LS, Oleszczuk M, et al. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews[J]. Cochrane Database Syst Rev, 2014, (2): D010314.
|
| 28 |
Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids[J]. Eur Respir J, 2002, 19(1): 182-191.
|
| 29 |
Rogers L, Hanania NA. Role of anticholinergics in asthma management：recent evidence and future needs[J]. Curr Opin Pulm Med, 2015, 21(1): 103-108.
|
| 30 |
Gupta P, O′Mahony MS. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing[J]. Drugs Aging, 2008, 25(5): 415-443.
|
| 31 |
Ohta K, Fukuchi Y, Grouse L, et al. A prospective clinical study of theophylline safety in 3 810 elderly with asthma or COPD[J]. Respir Med, 2004, 98(10): 1016-1024.
|
| 32 |
Bozek A, Warkocka-Szoltysek B, Filipowska-Gronska A, et al. Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients [J]. J Asthma, 2012, 49(5): 530-534.
|
| 33 |
Pelaia G, Vatrella A, Busceti MT, et al. Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments[J]. Curr Drug Targets, 2015, 16(2): 171-178.
|
| 34 |
Samitas K, Delimpoura V, Zervas E, et al. Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives[J]. Eur Respir Rev, 2015, 24(138): 594-601.
|
| 35 |
Zhang JY, Wenzel SE. Tissue and BAL based biomarkers in asthma[J]. Immunol Allergy Clin North Am, 2007, 27(4): 623-632.
|
| 36 |
Deeks ED. Mepolizumab: A review in eosinophilic asthma[J]. BioDrugs, 2016, 30(4): 361-370.
|